Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double Blinded, Placebo Controlled Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption

NCT03270085 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03270085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03270085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double Blinded, Placebo Controlled Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Completed
Start date
December 7, 2017
Completion date
May 31, 2019
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bile acid malabsorption, chronic diarrhea, irritable bowel syndrome with diarrhea